0001209191-17-046028.txt : 20170721 0001209191-17-046028.hdr.sgml : 20170721 20170721200535 ACCESSION NUMBER: 0001209191-17-046028 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170719 FILED AS OF DATE: 20170721 DATE AS OF CHANGE: 20170721 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Parini Michael CENTRAL INDEX KEY: 0001661567 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 17977413 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS, INC. STREET 2: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-07-19 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001661567 Parini Michael 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, CL&AO Common Stock 2017-07-19 4 M 0 8500 90.29 A 37309 D Common Stock 2017-07-19 4 M 0 2329 86.52 A 39638 D Common Stock 2017-07-19 4 S 0 10829 161.00 D 28809 D Stock Option (Right to Buy) 90.29 2017-07-19 4 M 0 8500 0.00 D 2026-07-11 Common Stock 8500 25500 D Stock Option (Right to Buy) 86.52 2017-07-19 4 M 0 2329 0.00 D 2027-02-02 Common Stock 2329 34949 D Transaction made pursuant to Mr. Parini's company approved trading plan under Rule 10b5-1. The option vests in 16 quarterly installments from 07/12/2016. The option vests in 16 quarterly installments from 02/03/2017. Omar White, Attorney-In-Fact 2017-07-21